US › Healthcare

Viemed Healthcare Inc (VMD)

US · Healthcare · Medical Devices

$8.95+0.11%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$78.1M

Revenue YoY

+23.9%

Net profit

$2.8M

Profit YoY

-12.4%

EPS

$0.07

EPS estimate

$0.10

Net margin

3.5%

EPS came in at 0.07 against a street estimate of 0.10 — a miss of 30.0%.

Key statistics

Market cap

$334.8M

P/E

24.4

Forward P/E

18.1

P/B

2.33

Book value

$3.78

EPS (TTM)

$0.36

52-week high

$12.61

52-week low

$6.05

50-day MA

$10.36

200-day MA

$9.19

Beta

1.09

Analyst view

Analysts rate Viemed Healthcare Inc a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $12.50.

Shareholding

Insiders

13.93%

Institutions

70.99%

Largest institutional holders

Fund	Stake
BlackRock Inc	12.14%
Forager Capital Management, LLC	5.62%
The Goldman Sachs Group Inc	3.73%
Vanguard Capital Management, LLC	3.42%
Arnhold & S. Bleichroeder Advisers, LLC	2.81%
Ameriprise Financial Inc	2.36%
Nantahala Capital Management, LLC	2.32%
Geode Capital Management, LLC	2.05%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Viemed Healthcare Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.